PURDUE’S NEW DRUG
Sackler, of Purdue Pharma, Gets Patent for Opioid Addiction Medication
I guess you could say what goes around, comes around. Things seem to have come full-circle in the opioid crisis and it’s not good news. Recently Dr. Richard Sackler, of Purdue Pharma, was given approval on a patent for a new, marvel form of buprenorphine to be used for the treatment of opioid addiction. That’s right, the man whose family owns the company thought to be responsible for the opioid crisis was just given permission to formulate a drug to fight the very thing his family may have helped to create.
